Carl Magnus Rudenstam

Summary

Country: Sweden

Publications

  1. ncbi Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93
    Carl Magnus Rudenstam
    West Swedish Breast Cancer Study Group, Sahlgrenska University Hospital Molndal, Göteborgsvägen 31, 431 80 Mölndal, Sweden
    J Clin Oncol 24:337-44. 2006
  2. ncbi The Gothenburg Breast Screening Trial
    Nils Bjurstam
    Department of Radiology, Center for Breast Imaging, University Hospital of North Norway, Tromsø, Norway
    Cancer 97:2387-96. 2003
  3. ncbi Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV
    Diana Crivellari
    Centro di Riferimento Oncologico, Via Pedemontana Occidentale 12, I 33081 Aviano, Italy
    J Clin Oncol 21:4517-23. 2003
  4. ncbi Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience
    Marco Colleoni
    Division of Medical Oncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    J Clin Oncol 23:1390-400. 2005
  5. ncbi Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Ca
    Günther Gruber
    Department of Radiation Oncology, and the Institute of Medical Oncology, Inselspital, Switzerland
    J Clin Oncol 23:7089-97. 2005
  6. ncbi Increased risk of recurrence after hormone replacement therapy in breast cancer survivors
    Lars Holmberg
    Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
    J Natl Cancer Inst 100:475-82. 2008

Detail Information

Publications6

  1. ncbi Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93
    Carl Magnus Rudenstam
    West Swedish Breast Cancer Study Group, Sahlgrenska University Hospital Molndal, Göteborgsvägen 31, 431 80 Mölndal, Sweden
    J Clin Oncol 24:337-44. 2006
    ..We therefore investigated whether avoiding axillary surgery in older women would result in improved quality of life (QL) with similar disease-free survival (DFS) and overall survival (OS)...
  2. ncbi The Gothenburg Breast Screening Trial
    Nils Bjurstam
    Department of Radiology, Center for Breast Imaging, University Hospital of North Norway, Tromsø, Norway
    Cancer 97:2387-96. 2003
    ..Although there is evidence for a reduction in breast carcinoma mortality with mammographic screening, some doubts have been expressed, and there is still uncertainty regarding the age specific effects...
  3. ncbi Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV
    Diana Crivellari
    Centro di Riferimento Oncologico, Via Pedemontana Occidentale 12, I 33081 Aviano, Italy
    J Clin Oncol 21:4517-23. 2003
    ..The role of adjuvant therapy for this population is still a matter of debate. We reviewed the long-term outcome of a mature trial comparing endocrine treatment versus no adjuvant therapy in older women with node-positive breast cancer...
  4. ncbi Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience
    Marco Colleoni
    Division of Medical Oncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    J Clin Oncol 23:1390-400. 2005
    ..For medial tumors, axillary lymph node staging may not accurately reflect the metastatic potential of the disease...
  5. ncbi Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Ca
    Günther Gruber
    Department of Radiation Oncology, and the Institute of Medical Oncology, Inselspital, Switzerland
    J Clin Oncol 23:7089-97. 2005
    ..We sought to determine retrospectively whether extracapsular spread (ECS) might identify a subgroup that could benefit from radiotherapy after mastectomy, especially patients with 1 to 3 positive lymph nodes (LN1-3+)...
  6. ncbi Increased risk of recurrence after hormone replacement therapy in breast cancer survivors
    Lars Holmberg
    Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
    J Natl Cancer Inst 100:475-82. 2008
    ..We present results after extended follow-up...